Cyclical travel demand — RevPAR and unit growth both soften in a recession, and 4.1× leverage amplifies it
One-line thesis. Hilton is a genuinely elite, capital-light hotel-franchising machine — ~45% adjusted-EBITDA margins, 6–7% unit growth, and a buyback engine that turns high-single-digit fee growth into ~16% EPS growth — but at 37× forward earnings the market already knows it, and with RevPAR decelerating to 2–3% there is no obvious edge left in the price. Watch, not Buy, until either the multiple resets or growth re-accelerates.
◆ Synthos call — HoldHLT is a solid business largely reflected at ~$340 — fine to keep, no reason to chase; it gets interesting again below ~$289.
Downside Risk (lower = safer)
6/10 · High
Asset-light & low-beta, but 51× trailing, 4.1× net-debt/EBITDA, negative equity and a cyclical demand base.
Growth Quality
7/10 · High
~16% forward EPS CAGR on 6-7% unit growth + buybacks; elite ~45% EBITDA margins & high ROIC, fee-based moat.
Exponential Potential
3/10 · Low
Great compounder but decelerating RevPAR (2-3%); a mature $77B lodging franchise — no multibagger runway.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Hilton doesn't mostly own hotels — it rents out its brand names (Hilton, Hampton, DoubleTree, Waldorf Astoria and dozens more) to the people who actually build and run them, and collects a fee off every room. That's a wonderful business: very high profit margins, almost no need to spend money on buildings, and it grows as more hotels open under Hilton's flags (6–7% more rooms a year). The company then buys back its own stock aggressively, which pumps up earnings-per-share even faster.
The catch: the stock is expensive. You're paying about 37 dollars for every dollar of next year's expected profit — a premium price for a company whose core "same-store" growth is only running 2–3% a year. Our verdict is Watch: it's a great company, but the price already reflects that, so there's little bargain here today.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). The business is steady and the stock isn't wild, but it carries a lot of debt, the price is high, and hotel demand falls in a recession — so a stumble would hurt.
Growth Quality 7/10 (good). Reliable, high-margin, well-run growth — just not explosive.
Exponential Potential 3/10 (low). This is a mature, established company. Expect steady compounding, not a stock that doubles quickly.
The one big worry: travel is cyclical. In a recession people take fewer trips, hotels fill fewer rooms, and Hilton's fee income and new-hotel openings both slow at the same time the debt bill stays fixed.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = HLT · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$338.12
Market cap$77B
P/E trailing15×
P/E FY26E / FY27E37× / 33×
EV / Sales7.3×
EV / EBITDA29.8×
Gross margin44.3%
Net margin12.6%
Dividend yield0.18%
Beta1.053
52-wk range$257 – $350
RSI(14)45
50 / 200-DMA$330 / $299
12-mo return+26% (SPY +21%)
Street target$342 ($312–$373)
Analyst grades27 Buy · 22 Hold · 0 Sell
FMP ratingC+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on HLT · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Hilton Worldwide (NYSE: HLT) is a ~106-year-old global hospitality company that has deliberately shed hotel ownership to become an asset-light manager and franchisor of hotel brands. It reports in two segments — Management & Franchise and Ownership — but the economic engine is the fee business: Hilton licenses ~25 brands (from Hampton and Hilton Garden Inn at the value/mid end to Waldorf Astoria, Conrad and LXR at the luxury end, plus lifestyle labels like Canopy, Tempo, Motto, Graduate and the new Select by Hilton) to third-party owners and collects royalty, base-management and incentive fees. Fiscal year ends December 31. CEO Christopher Nassetta has run the company since before its 2013 IPO.
The key operating metrics are RevPAR (revenue per available room — the "same-store" gauge) and net unit growth / NUG (how fast the room count expands). As of Q1'26 the development pipeline hit a record 527,000 rooms (~3,768 hotels), with more than half outside the U.S. and almost half under construction — the forward fuel for 6–7% NUG.
Revenue mix (FY2025, from filings):
By type: Reimbursement revenue $7.09B (pass-through cost recoveries — high dollars, near-zero margin) · Management & Franchise $2.78B (the high-margin fee core) · Management Service base $0.38B + incentive $0.31B · Hotel/Other $0.25B. Note: the huge "Reimbursement Revenue" line is largely a pass-through — the true profit engine is the ~$3.5B of fee revenue.
By geography (FMP split): United States $9.52B (79%) · Non-US $2.52B (21%). Heavily US-weighted demand base — a domestic-macro strength and a concentration risk.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of HLT in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0, and there are no claim_ids to reconcile. Honesty is the product, so we state it plainly: this verdict carries no conviction-panel signal and is entirely fundamentals- and quant-driven. Nothing in this note should be read as expert-sourced; every judgment below is Synthos's own reading of the FMP financials, analyst estimates, and management's SEC-filed guidance.
For external context only (not Synthos conviction), the sell-side is constructive-but-not-emphatic: 27 Buy / 22 Hold / 0 Sell, consensus rating "Buy," with a price-target consensus of $342.3 essentially on top of the current $338 — i.e. the Street sees HLT as roughly fairly valued, which aligns with our own Watch call.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Moderate-High
Beta ~1.05 and an asset-light, cash-generative model temper risk, but 51× trailing / 37× forward leaves no cushion, net-debt/EBITDA is 4.1×, book equity is negative (aggressive buybacks), and lodging demand is cyclical.
Growth Quality
7 · Good
~16% forward EPS CAGR built on 6–7% unit growth + fee escalation + buybacks; ~45% adjusted-EBITDA margins, high returns on capital, a durable brand/network moat. Docked because the growth is buyback-levered and RevPAR is soft.
Exponential Potential
3 · Low
RevPAR growth is only 2–3% and decelerating; a mature $77B franchise with a well-understood model. Steady compounder, not a multibagger. A small, fast-NUG lodging name would score far higher.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Guidance roughly hits — FY26 adj EPS ~$8.85, FY27E ~$10.38; a durable high-single-digit-NUG compounder earns a ~33× forward multiple on FY27E.
~$340 (~flat)
Bear
Consumer/travel recession: RevPAR turns negative, NUG slows, buybacks throttle. FY27E adj EPS misses to ~$9; multiple de-rates to ~28× as cyclicality reasserts.
~$250 (−26%)
Synthos fair value = the base case, ~$340 (~flat to spot), with the full $250–$430 span as the honest range. This anchor sits essentially on top of the Street's $342.3 consensus — we and the sell-side agree the stock is close to fair value here, which is precisely why the verdict is Watch rather than Buy. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). HLT is a high-quality compounder with essentially no exponential profile:
Forward growth: revenue CAGR FY25→FY30E ~8.0% ($12.04B → $17.69B); adjusted EPS CAGR FY26→FY30E ~16% ($9.03 → $16.36) — the gap between the two is buybacks and margin/fee mix, not organic demand.
Acceleration (the 2nd derivative) is flat-to-negative: management's own guide is RevPAR +2–3% for FY26, below the 3.6% Q1'26 print — same-store growth is decelerating, and revenue growth settles into a high-single-digit lane. There is no inflection here; the pandemic recovery is long finished.
Room to run: at $77B market cap in a mature, competitive global lodging market (Marriott alone is ~$98B), the TAM is large but Hilton's share is already substantial and the network is built out. A 3–5× from here is not a credible path.
Reinvestment runway: genuinely capital-light — capex guided to only ~$300M/yr — so incremental fee dollars convert to cash at very high rates. But that cash funds buybacks, not a new growth vector. It compounds; it does not exponentiate.
Exponential Potential: Low (3/10). Own HLT — if at all — for durable, buyback-amplified mid-teens EPS compounding, not for a fast multibagger. This is squarely a Core-sleeve-quality business trading at a Core-sleeve price, with none of the accelerating-small-cap characteristics that earn a high exponential score.
Revenue: FY25 $12.04B, +7.7% (FY24 $11.17B, +9.2% on FY23 $10.24B). Steady mid-to-high-single-digit growth — but note ~$7.1B of that is low-margin pass-through reimbursement.
Margins: the fee model shows up in profitability — gross 44.3% TTM, EBIT 22.9% TTM, and management-defined Adjusted EBITDA margin ~45% of fee-relevant revenue (FY26 adj EBITDA guided $4.02–4.06B). Elite for the sector.
Earnings: GAAP net income $1.46B FY25 (EPS $6.18; diluted $6.12); the adjusted diluted EPS the Street tracks was ~$8.07 FY25 → guided $8.79–8.91 FY26. Q1'26 GAAP diluted EPS $1.66, adjusted $2.01.
Cash flow: operating CF $2.13B, capex only −$185M, FCF $1.94B FY25 — a ~93% FCF/operating-CF conversion that funds the buyback. FCF yield ~2.5–2.8%.
Balance sheet (read carefully): total debt $15.7B, net debt $14.7B, net-debt/EBITDA 4.1× TTM. Total stockholders' equity is negative (−$5.4B) and book value per share is negative — this is by design (Hilton has repurchased ~$14.4B of treasury stock), not distress, but it means leverage and ROE ratios are not meaningful in the usual way. The real question is interest coverage: EBIT/interest ~4.5× — adequate but not fortress-like.
6. Valuation — priced in or room?
There is no way to call HLT cheap. On trailing GAAP it's 51× EPS; on the adjusted EPS the Street uses it's 37× FY26E, 33× FY27E, and ~21× FY30E; EV/EBITDA is 29.8× and EV/sales 7.3×. The bull's defense is the usual quality-compounder argument — that EPS grows into the multiple: FY30E adjusted EPS of $16.36 against today's $338 is only ~21×, so a patient holder is "paying 21× for 2030." That's fair, but it requires four more years of clean execution and a still-premium exit multiple, with no margin for a travel downturn.
A reverse read: at $338 the market is pricing roughly the guided high-single-digit revenue / mid-teens EPS CAGR to persist — i.e. HLT is priced for its plan, with little upside surprise embedded and real downside if RevPAR rolls over. Street targets (context): consensus $342.3, high $373, low $312 — the whole sell-side range brackets the current price tightly, confirming a fully-valued read. Our base-case FV of ~$340 lands in the same place. Not a value buy, not even a growth-at-a-reasonable-price buy today — a great-business-at-a-full-price that we'd rather Watch for a pullback.
7. Technicals (from the FMP tech block)
Trend:up. $338 sits above the 50-DMA ($330) and 200-DMA ($299), with the 50 above the 200 (golden-cross posture). MACD +1.15 (mildly positive).
Location:−3.5% off the 52-week high ($350) and +31.7% off the 52-week low ($257) — a leadership name near highs, with a shallow max drawdown of only −3.5% from peak.
Momentum: RSI(14) 45 — neutral, neither overbought nor oversold. No stretched-entry signal, but also no washed-out dip to buy.
Relative strength: HLT +25.7% 12-mo vs SPY +20.6% (modest outperformance) but QQQ +30.3% over the same window — HLT lags the growth tape. 3-mo: +9.7% vs SPY +13.7% and QQQ +22.0% — recently trailing both.
Read: technicals are constructive (uptrend, above both moving averages) but not a green-light — RSI is neutral, recent relative strength is fading, and price is near the top of its range. Consistent with the fundamental Watch: no urgency to chase; a dip toward the 200-DMA (~$300) would be a materially better entry.
8. Moat & competitive position
Hilton's moat is a classic asset-light network effect: (1) brand portfolio — ~25 brands spanning every price point, so an owner can flag almost any property under a Hilton banner; (2) the Hilton Honors loyalty program — ~200M+ members who drive direct, repeat, lower-cost bookings and give owners a reason to pay for the flag; and (3) scale in distribution and RevPAR delivery, which lets Hilton win development deals (record 527k-room pipeline) and compound unit growth at low capital intensity. Switching costs for owners (long-term franchise/management contracts) reinforce durability. The model is proven and hard to disrupt — but it is not unique; Marriott runs the same playbook at larger scale.
Peer set (market cap, from FMP): Marriott $98B (the direct lodging comp), Airbnb $88B, Royal Caribbean $79B, GM $69B, Ross Stores $68B, Ferrari $68B, AutoZone $52B, Ford $52B, Coupang $33B, Trip.com $26B. Within lodging, HLT and MAR are the two premium franchisors; HLT's multiple is rich but broadly in line with MAR's for a similar-quality, similar-growth model — neither is a bargain.
9. Management, capital allocation & guidance
Capital allocation: shareholder-return-first. FY26 guides ~$3.5B of total capital return (buybacks + a $0.15/qtr dividend) against ~$1.9B of FCF and modest incremental leverage — i.e. Hilton borrows to buy back stock, which is what drives the negative book equity and the 4.1× leverage. At a high ROIC and a capital-light model this is defensible, but it does mean EPS growth is manufactured in part by share-count reduction (diluted shares fell from ~264M in 2023 to ~232M in Q1'26).
Insider activity: the recent Form 4s (all 2026-06-30/07-01) are routine director stock awards (A-Award, $0 price), not open-market buying or selling — no signal either way.
Management's own guidance (SEC 8-K, Q1'26 earnings release, dated 2026-04-28 — half-weighted; these are management's self-interested words): Hilton raised its full-year outlook. FY26: system-wide RevPAR +2.0% to +3.0% (currency-neutral); adjusted diluted EPS $8.79–$8.91 (GAAP $8.28–$8.40); net income $1,909–$1,937M; Adjusted EBITDA $4,020–$4,060M; net unit growth 6.0–7.0%; capex ~$300M; capital return ~$3.5B. Q2'26: RevPAR +2–3%, adjusted diluted EPS $2.18–$2.24, Adjusted EBITDA $1,015–$1,035M. CEO Nassetta cited "strengthening demand trends since late 2025 supported by macroeconomic tailwinds most evident in the U.S." and a record development pipeline. Treat as management's book: credible given the Q1 beat, but RevPAR guidance of 2–3% below the 3.6% Q1 print is the honest tell that same-store growth is set to slow.
10. Catalysts & what to watch
Next earnings: 2026-07-28 (Q2'26; Street EPS $2.27, revenue ~$3.32B; management guided adjusted diluted EPS $2.18–2.24). The key lines: RevPAR (is 2–3% holding or softening?) and net unit growth.
RevPAR trend: any move toward flat/negative RevPAR is the single biggest swing factor — it hits the highest-margin fee line directly.
Development pipeline / NUG: the 527k-room pipeline is the forward growth fuel; watch signings and openings, especially the >50% that is international.
Buyback pace: ~$3.5B guided; a pullback in repurchases (or a leverage cap) would slow EPS growth mechanically.
Macro / travel demand: US consumer and corporate-travel health, given the ~79% US revenue weight.
Thesis tripwires (what would change the call): two consecutive quarters of negative RevPAR; NUG slipping below 5%; net-debt/EBITDA pushing past ~4.5×; or a buyback pause. A de-rate toward ~28× on any of these is the bear path; conversely, a pullback to the low-$300s / 200-DMA on no fundamental change would flip us from Watch toward Buy.
11. Key risks
Cyclicality (structural): lodging demand is economically sensitive; a consumer or corporate-travel recession hits RevPAR and NUG simultaneously, and 4.1× leverage amplifies the earnings swing.
Valuation / de-rating: 37× forward leaves no margin for a demand or RevPAR disappointment; the whole thesis assumes a premium multiple persists.
Leverage & negative equity: $15.7B debt, 4.1× net-debt/EBITDA, negative book equity — deliberate, but it removes balance-sheet slack in a downturn and makes the buyback engine sensitive to rates and cash flow.
Buyback-dependent EPS: a meaningful chunk of forward EPS growth comes from share-count reduction, not organic demand — higher rates or a cash-flow hit would slow it.
Competitive & disruption: Marriott at larger scale, plus Airbnb and alternative accommodation, compete for both travelers and (indirectly) owner capital.
No expert corroboration: zero Synthos KB coverage — this call has no independent conviction-panel signal behind it.
12. Verdict, position sizing & monitoring
Watch. Hilton is a genuinely elite, capital-light franchising machine — ~45% adjusted-EBITDA margins, 6–7% unit growth, a record pipeline, and a buyback engine that turns high-single-digit fee growth into ~16% EPS compounding. The problem is entirely the price: at 37× forward earnings with RevPAR guided to decelerate to 2–3%, the market already pays full value, our base-case FV (~$340) sits right on the current price and the Street's consensus, and there's no margin of safety against the cyclicality. Great business, unremarkable entry.
Sizing: if already owned, a ~1–3% cyclical-quality position is reasonable; we would not initiate a high-conviction add at $338. Wait for a pullback toward the 200-DMA (~$300) or evidence of RevPAR re-acceleration.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $338.12.
Single biggest risk: cyclical travel demand — RevPAR and unit growth soften together in a downturn while the debt bill stays fixed.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — HLT has no expert coverage in the Synthos knowledge base. This note is fundamentals- and quant-driven; no claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: Q1'26 8-K guidance is management's own book, half-weighted by design; RevPAR guidance below the latest print is flagged.
Adjusted vs GAAP: the Street and management track adjusted diluted EPS (~$8.85 FY26E), materially above GAAP diluted EPS ($6.12 FY25); trailing P/E uses GAAP, forward P/E uses adjusted — both are shown to avoid overstating cheapness.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").